The issue: All strengths of both hydrocortisone and methylprednisolone sodium succinate vials are on reduced monthly order allocation with varying resupply dates throughout the remainder of 2023.
The issue: Verapamil 180 mg sustained release (SR) and 240 mg SR tablets are on backorder in Canada. NH stock levels are low and unlikely to meet current demands. Inventory may be depleted prior to resolution of this shortage.
The issue: The single source vendor of lidocaine 1% and 2% with EPINEPHrine 1:100,000 X 20 mL vials is on backorder. Several NH sites have low stock in pharmacies and wardstock areas, and alternate options will need to be used when supply is depleted.
The issue: The single source vendor of betamethasone 6 mg/mL injection (1 mL and 5 mL vials) is on backorder. NH has approximately 6-7 weeks of stock in pharmacies and clinical areas, and the alternate option will need to be used when supply is depleted.
The issue: Erythromycin 333 mg SR oral tablets (ERYC®) have been discontinued in Canada, and there are no other solid oral erythromycin dosage forms currently available. NH has low stock remaining.
COVID-19 testing performed on ID NOW instruments in emergency rooms across NHA has been permanently discontinued, effective immediately.
March 2023 formulary update - effective March 24, 2023
Included in the update: